FIS103, a Novel SULT1A1-dependent Prodrug, Demonstrates Potent Antitumor Activity in Renal Cell Carcinoma
Preprint in medRxiv (March 2024)
The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.
Preprint in medRxiv (March 2024)
Article in Journal of Translational Medicine (March 2023)
Article in Free Radical Biology and Medicine (November 2022)